Clinical Trial Update: Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating whether adding nicotinic acid to simvastatin improves carotid and femoral intima-media thickness in patients with per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Dyslipidemia
• Peripheral Artery Disease

Drugs mentioned

• Nicotinic acid (niacin)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Medical University of Vienna | Conditions: Dyslipidemia, Atherosclerosis | Phase 4 | Status: UNKNOWN